<DOC>
	<DOCNO>NCT02712840</DOCNO>
	<brief_summary>The purpose study determine whether chance become pregnant well day single best day 5 embryo ( blastocyst ) result vitro fertilization ( IVF ) cycle transfer uterus immediately , freeze embryo transfer uterus subsequent cycle , separate ovarian stimulation use IVF cycle . The investigator hypothesize good-prognosis patient , vitrified-warmed elective single embryo transfer result high implantation , clinical on-going pregnancy live birth rate fresh elective single embryo transfer blastocyst stage .</brief_summary>
	<brief_title>Comparing Pregnancy Outcomes Good Prognosis Patients Between Fresh 'Freeze-All ' Single Blastocyst Transfers</brief_title>
	<detailed_description>This randomize controlled trial involve good prognosis infertility patient undergo vitro fertilization ( IVF ) +/- intracytoplasmic sperm injection ( ICSI ) . Good prognosis define : age &lt; 35 year , 1st IVF IVF/ICSI cycle , normal ovarian reserve parameter ( antral follicle count ( AFC ) &gt; 12 , antimullerian hormone ( AMH ) &gt; 15 pmol/L , cycle day 3 follicle stimulate hormone ( FSH ) &lt; 10 IU ) , primarily tubal factor/male factor ejaculate sperm unexplained infertility , achieve 3 high quality blastocyst ( adequate quality either fresh embryo transfer cryopreservation 5 day post-oocyte-retrieval ) . All participant undergo IVF/ICSI cycle utilize either long gonadotropin release hormone ( GnRH ) agonist GnRH antagonist protocol . In long GnRH agonist cycle , participant take combine oral contraceptive pill ( OCP ) 21-42 day . The GnRH agonist buserelin acetate ( 0.2 mg subcutaneously daily ) start 5 day last OCP take , 5-day overlap , continue day hCG trigger . In GnRH antagonist cycle , woman either down-regulated oral combine contraceptive pill ( OCP ) 14-21 day , start cycle day 3 pre-stimulation cycle , estrogen 4 mg orally daily start approximately 7 day post-ovulation pre-stimulation cycle . Participants continue OCP estrogen designate stop day determine clinic schedule . In agonist antagonist cycle , FSH give patient either recombinant human menopausal gonadotropin ( HMG ) form , dose range 150 IU ( international unit ) 300 IU daily , per investigator judgment . FSH start either natural day 3 follow OCP estrogen withdrawal , 'assigned ' day 3 , base scheduling requirement . The FSH dose maintain 4 day , dose titration occur accord result follicular development see transvaginal ultrasonography serum estradiol level , first occurs cycle day 7 . Continued ultrasonographic serum level monitoring occur every 1-2 day time human chorionic gonadotropin ( hCG ) trigger . In GnRH antagonist cycle , GnRH agonist start dose 250 mcg daily follow first occurs : cycle day 9 , estradiol level &gt; 2000 pmol/L , lead follicle &gt; 14 mm diameter , continue time hCG trigger . Timing hCG ( 5000-10,000 IU ) administration occur least three lead follicle diameter &gt; 17 mm . Oocyte retrieval perform 36 hour hCG administration . Fertilization utilize either routine IVF ICSI , depend upon etiology infertility quality sperm . With ICSI , mature oocyte inseminate . Embryo evaluation occur per clinic 's standard protocol . Embryo assessment day 5 post-fertilization dictate final eligibility study enrollment . Consenting participant 3 cryopreservation-quality blastocyst ( 2BB high , grade accord Gardner 's criterion ) randomize either fresh single embryo transfer ( SET ) ( cryopreservation good quality supernumerary blastocyst ) single frozen embryo transfer ( FET ) delay subsequent menstrual cycle follow cryopreservation good quality blastocyst . All FET cycle perform standard endometrial preparation protocol involve vaginal estradiol administration approximately 14 day . Luteal support either fresh FET cycle vaginal micronized progesterone , 200 mg vaginally 2-3 time daily , start day follow fresh ET , 6 day prior FET , document endometrial thickness 8 mm achieve . The best quality blastocyst transfer first . Should best blastocyst survive warm FET group , second-best blastocyst use . All cryopreservation perform vitrification . Luteal phase progesterone continue either 10 week gestation ( ongoing pregnancy ) document negative serum hCG level drawn 14 day date embryo transfer . With documented positive hCG serum level , participant undergo transvaginal ultrasound 7 week gestation document number gestational sac ( implantation ) clinical pregnancy rate ( positive fetal heart beat ) . Confirmation ongoing pregnancy ( beyond 12 week gestation ) obtain review hospital record ultrasounds performed nuchal translucency measurement anatomic assessment . Randomization blastocyst stage choose avoid cycle cancellation randomize earlier . All participant randomize intention treat approach . All component IVF/ICSI cycle include stimulation medication , monitoring protocol , etc . discretion participant 's primary IVF physician ; information document constitute criterion enrollment . Each successive enrol participant randomize choose sequentially number , opaque , seal envelope assign either freeze-all fresh transfer group , base upon envelope content derive use computer generate block randomization , utilizing random block size 4 6 participant , 1:1 allocation . The envelop content provide independent individual involve study recruitment clinical care participant .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>First IVF cycle Normal ovarian reserve parameter ( antral follicle count &gt; 12 , follicle stimulate hormone ( FSH ) &lt; 10 IU/L , AMH ( measure ) &gt; 15 pmol/L ) Infertility cause due tubal factor , male factor ejaculate sperm unexplained 3 fresh transfer cryopreservationquality blastocyst day 5 postoocyteretrieval GnRH antagonist long GnRH agonist cycle Evidence ( evidence significant risk ) ovarian hyperstimulation syndrome ( OHSS ) postoocyteretrieval day 5 ( standard protocol perform fresh embryo transfer , rather freeze blastocyst future frozen embryo transfer ) . Use gonadotropin release hormone ( GnRH ) agonist trigger ovulation result intensive luteal phase support protocol . Women require automatic freezeall approach ( preimplantation genetic test cryopreservation fertility preservation ) . Female infertility cause may adversely affect implantation , severe endometriosis , fibroid , mullerian abnormality , prior uterine procedure result potentially compromise endometrial cavity . Invitro maturation oocytes Oocyte donation cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Single embryo transfer</keyword>
	<keyword>Freeze-all</keyword>
	<keyword>Fresh</keyword>
	<keyword>Vitrification</keyword>
	<keyword>Clinical Pregnancy</keyword>
	<keyword>Blastocyst</keyword>
</DOC>